Cargando…

Will LEDGIN molecules be able to play a role in a cure for HIV infection?

Detalles Bibliográficos
Autores principales:	Mesplède, Thibault, Wainberg, Mark A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919589/ https://www.ncbi.nlm.nih.gov/pubmed/27428407 http://dx.doi.org/10.1016/j.ebiom.2016.05.007

Ejemplares similares

Integrase Strand Transfer Inhibitors in HIV Therapy
por: Mesplède, Thibault, et al.
Publicado: (2013)

Resistance against Integrase Strand Transfer Inhibitors and Relevance to HIV Persistence
por: Mesplède, Thibault, et al.
Publicado: (2015)

Implications for the future of the HIV epidemic if drug resistance against dolutegravir cannot occur in first-line therapy
por: Wainberg, Mark A, et al.
Publicado: (2015)

What if HIV were unable to develop resistance against a new therapeutic agent?
por: Wainberg, Mark A, et al.
Publicado: (2013)

Nonhuman Primates and Humanized Mice for Studies of HIV-1 Integrase Inhibitors: A Review
por: Hassounah, Said A., et al.
Publicado: (2016)

Impact of LEDGIN treatment during virus production on residual HIV-1 transcription
por: Vansant, Gerlinde, et al.
Publicado: (2019)

Effect on HIV-1 viral replication capacity of DTG-resistance mutations in NRTI/NNRTI resistant viruses
por: Pham, Hanh T., et al.
Publicado: (2016)

LEDGINs, a novel class of antivirals targeting HIV integrase during integration and assembly
por: Debyser, Zeger
Publicado: (2013)

HIV drug resistance against strand transfer integrase inhibitors
por: Anstett, Kaitlin, et al.
Publicado: (2017)

LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions
por: Desimmie, Belete Ayele, et al.
Publicado: (2013)

Is Resistance to Dolutegravir Possible When This Drug Is Used in First-Line Therapy?
por: Mesplède, Thibault, et al.
Publicado: (2014)

Correction to: LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions
por: Desimmie, Belete Ayele, et al.
Publicado: (2020)

LEDGF/p75-Independent HIV-1 Replication Demonstrates a Role for HRP-2 and Remains Sensitive to Inhibition by LEDGINs
por: Schrijvers, Rik, et al.
Publicado: (2012)

LEDGIN-mediated Inhibition of Integrase–LEDGF/p75 Interaction Reduces Reactivation of Residual Latent HIV
por: Vranckx, Lenard S., et al.
Publicado: (2016)

Cenicriviroc blocks HIV entry but does not lead to redistribution of HIV into extracellular space like maraviroc
por: Kramer, Victor, et al.
Publicado: (2014)

Structural Studies of the HIV-1 Integrase Protein: Compound Screening and Characterization of a DNA-Binding Inhibitor
por: Quashie, Peter K., et al.
Publicado: (2015)

Correction: LEDGF/p75-Independent HIV-1 Replication Demonstrates a Role for HRP-2 and Remains Sensitive to Inhibition by LEDGINs
por: Schrijvers, Rik, et al.
Publicado: (2020)

HIV-1 group O integrase displays lower susceptibility to raltegravir and has a different mutational pathway for resistance than HIV-1 group M
por: Depatureaux, Agnès, et al.
Publicado: (2014)

The R263K mutation in HIV integrase that is selected by dolutegravir may actually prevent clinically relevant resistance to this compound
por: Wainberg, Mark, et al.
Publicado: (2014)

HIV and Zika: When will we be able to end these epidemics?
por: Wainberg, Mark A., et al.
Publicado: (2016)

HIV Infection of Macrophages: Implications for Pathogenesis and Cure
por: Clayton, Kiera L., et al.
Publicado: (2017)

Multifarious immunotherapeutic approaches to cure HIV-1 infection
por: Imami, Nesrina, et al.
Publicado: (2015)

CRISPR/Cas9: a double-edged sword when used to combat HIV infection
por: Liang, Chen, et al.
Publicado: (2016)

Fitness Impaired Drug Resistant HIV-1 Is Not Compromised in Cell-to-Cell Transmission or Establishment of and Reactivation from Latency
por: Bastarache, Sophie M., et al.
Publicado: (2014)

Does antiretroviral treatment change HIV-1 codon usage patterns in its genes: a preliminary bioinformatics study
por: Palanisamy, Navaneethan, et al.
Publicado: (2017)

A Mathematical Model to Predict HIV Virological Failure and Elucidate the Role of Lymph Node Drug Penetration
por: Sanche, S, et al.
Publicado: (2017)

A Cure for HIV Infection: “Not in My Lifetime” or “Just Around the Corner”?
por: Lederman, Michael M., et al.
Publicado: (2016)

The M50I polymorphic substitution in association with the R263K mutation in HIV-1 subtype B integrase increases drug resistance but does not restore viral replicative fitness
por: Wares, Melissa, et al.
Publicado: (2014)

The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration
por: Mesplède, Thibault, et al.
Publicado: (2017)

HIV “cure”: A shot in the arm?
por: Peluso, Michael J., et al.
Publicado: (2019)

Finding a cure for HIV: will it ever be achievable?
por: Lewin, Sharon R, et al.
Publicado: (2011)

Automethylation of protein arginine methyltransferase 6 (PRMT6) regulates its stability and its anti-HIV-1 activity
por: Singhroy, Diane N, et al.
Publicado: (2013)

25 years of HIV-1 research – progress and perspectives
por: Wainberg, Mark A, et al.
Publicado: (2008)

Erratum for Mesplède et al., “The R263K Dolutegravir Resistance-Associated Substitution Progressively Decreases HIV-1 Integration”
por: Mesplède, Thibault, et al.
Publicado: (2018)

HIV persistence in the CNS: the final frontier for a cure?
por: Lewin, Sharon R, et al.
Publicado: (2016)

EnABLing microprocessor for apoptosis
por: Tu, Chi-Chiang, et al.
Publicado: (2015)

How Much HIV is Alive? The Challenge of Measuring Replication Competent HIV for HIV Cure Research
por: Ananworanich, Jintanat, et al.
Publicado: (2015)

The latest evidence for possible HIV-1 curative strategies
por: Pham, Hanh Thi, et al.
Publicado: (2018)

Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressure
por: Mesplède, Thibault, et al.
Publicado: (2013)

The role of unintegrated DNA in HIV infection
por: Sloan, Richard D, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_rcfdca41mej5jdctf4v1hnddm4